Publications
565
Citations
60,178
Est. group size
—
Recurring co-author estimate
Active years
54
Publishing since 1973
Carol R. Bradford's work focuses on head and neck cancer, particularly HPV-related oropharyngeal squamous cell carcinoma, examining how treatment intensity, surgery, and biomarkers can be tailored to individual patients to improve outcomes while reducing side effects. Her research spans clinical strategies such as de-escalated chemoradiotherapy, salvage surgery, immunotherapy, and the use of blood-based markers (like circulating tumor HPV DNA and neutrophil/lymphocyte ratios) to predict prognosis and guide decision-making.
Publication output has fluctuated over the past decade, with notable peaks in 2018 and 2023 and a decline in the most recent years, averaging about 16 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Selection Criteria for De-Escalated Chemoradiotherapy for HPV-Related Oropharyngeal Cancer Based on Prognostic Biomarkers or Early Tumor Response to Therapy: A Narrative Review
Diagnostics · 2026
- Immunotherapeutic Approaches to Head and Neck Squamous Cell Carcinoma: Current Clinical Practice and Future Directions
Head & Neck · 2026
- Global Incidence and Mortality of Myocardial Infarction in Multi-Modality Head and Neck Cancer Treatment: A Systematic Review and Meta-analysis
Advances in Therapy · 2025
- Head and Neck Cancer Salvage Surgery in the Era of Immunotherapy and Beyond
JAMA Otolaryngology–Head & Neck Surgery · 2025
- The Value of Circulating Tumor HPV DNA in Head and Neck Squamous Cell Cancer: A Review
Diagnostics · 2025
- Self-Care for Otolaryngologists
Otolaryngologic Clinics of North America · 2025
- WS13.04Management of intermediate sweat chloride results and diagnosis of CFTR related disorders in a large tertiary paediatric centre
Journal of Cystic Fibrosis · 2025
- Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx
Head & Neck · 2025
- From Radical Resection to Precision Surgery: Integrating Diagnostic Biomarkers, Radiomics-Based Predictive Models, and Perioperative Systemic Therapy in Head and Neck Oncology
Diagnostics · 2025
- Enhanced placental antibody transfer efficiency with longer interval between maternal respiratory syncytial virus vaccination and birth
American Journal of Obstetrics and Gynecology · 2024
- Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCC
Clinical Cancer Research · 2024
- Listening to School Nurses' Voices: A Mixed Methods Study on the Continued Impact of COVID-19 on School Nursing Practice
The Journal of School Nursing · 2024
- Supplementary Table S1 from Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV<sup>+</sup> OPSCC
2024
- Data from Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV<sup>+</sup> OPSCC
2024
- Supplementary Table S2 from Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV<sup>+</sup> OPSCC
2024
- Head & Neck×21
- Otolaryngology×15
- International Journal of Radiation Oncology*Biology*Physics×13
- Cell Reports×11
- JAMA Otolaryngology–Head & Neck Surgery×11
- Amit Agrawal
Medicine · The Ohio State University
- Enver Özer
Medicine · The Ohio State University
- Stephen Y. Kang
Medicine · The Ohio State University
- Hsing‐Hui Wang
Medicine · Purdue University West Lafayette
- Darrion Mitchell
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile